mdlinx mdlinx

Family Medicine - Psychiatry News & Articles

MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the 'headlines' covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, General Family Medicine News and many more.

Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Family Medicine!

Articles

Latest (18) Full Text Articles (848) Focus on Diabetes Mellitus
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

921 Open-label pilot study on vitamin D3 supplementation for antipsychotic-associated metabolic anomalies International Clinical Psychopharmacology, May 22, 2013    Clinical Article

922 Tobacco use by sexual identity among young adults in the united states Nicotine & Tobacco Research, May 22, 2013    Clinical Article

923 A longitudinal study of drinking and depression as predictors of insomnia in alcohol-dependent individuals Substance Use & Misuse, May 22, 2013    Clinical Article

924 Influence of a relaxation session and an exercise class on emotional states in pregnant women Journal of Reproductive and Infant Psychology, May 22, 2013    Clinical Article

925 CERAD practice effects and attrition bias in a dementia prevention trial International Psychogeriatrics, May 22, 2013    Clinical Article

926 Self-attributed seasonality of mood and behavior: a report from the netherlands study of depression and anxiety Depression and Anxiety, May 22, 2013    Clinical Article

927 High rate of disease-related copy number variations in childhood onset schizophrenia Full Text Molecular Psychiatry, May 22, 2013    Clinical Article

928 Antenatal prediction of postpartum depression with blood DNA methylation biomarkers Full Text Molecular Psychiatry, May 22, 2013    Clinical Article
Exclusive Author Commentary

929 Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17year-old adolescents Psychoneuroendocrinology, May 22, 2013    Clinical Article

930 Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial Psychotherapy and Psychosomatics, May 22, 2013    Clinical Article

931 Prevalence of hepatitis c virus infection in alcoholic patients: cohort study and systematic review Alcohol and Alcoholism , May 22, 2013    Clinical Article

932 Substance abuse treatment modalities and outcomes in a naturalistic setting Addictive Disorders & Their Treatment , May 22, 2013    Clinical Article

933 Vascular risk factors and neuropsychiatric symptoms in Alzheimers disease: the cache county study International Journal of Geriatric Psychiatry, May 22, 2013    Clinical Article

934 Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients Schizophrenia Research, May 22, 2013    Clinical Article

935 Alcohol consumption and self-reported (SF12) physical and mental health among working aged-men in a typical Russian city: A cross sectional study Addiction, May 22, 2013    Clinical Article

936 Smell identification function as a severity and progression marker in alzheimers disease International Psychogeriatrics, May 22, 2013    Clinical Article

937 Alcohol use and alcohol-use disorders among older adults in India: a literature review Aging and Mental Health, May 22, 2013    Clinical Article

938 Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in chinese adolescents: a multi-wave longitudinal study Full Text BMC Psychiatry, May 22, 2013    Clinical Article

939 Drinking motives moderate the impact of predrinking on heavy drinking on a given evening and related adverse consequences - An event-level study Addiction, May 22, 2013    Clinical Article

940 Comparative performance of biomarkers of alcohol consumption in a population sample of working-aged men in russia: the izhevsk family study Addiction, May 22, 2013    Clinical Article

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 Next Last

Clinical Pearls in Family Medicine

Highlights in Family Medicine

Vitamin D supplementation decreases systemic inflammation in T2DM

In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.

Read the article summary

Mediterranean diet associated with decreased diabetes, cardiovascular events, and all-cause mortality

Researchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.

Read the article summary

Natalizumab superior to IFN-? 1a in MS patients

Based on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Family Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close